Micardis 40mg (30’s)
Indication: Essential HTN. Reduction of the risk of MI, stroke or death in patients ≥55 yr at high risk developing major CV events who are unable to take ACE inhibitors. High risk CV events including evidence of CAD, peripheral arterial disease, stroke, transient ischemic attack or DM w/ evidence of end-organ damage. Additional treatment to antihypertensive, antiplatelet or lipid-lowering therapy.
*Images might not reflect the actual packaging of products